Search clinical trials for: GC1008

Total 166 results

Maximilian Diehn
Varian Medical Systems

Completed

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
Boston University

Completed

Fresolimumab In Systemic Sclerosis

Diffuse Systemic Sclerosis

United States
University Medical Center Groningen
Genzyme, a Sanofi Company

Completed

Safety and Imaging Study of GC1008 in Glioma

Primary Brain Tumors

Netherlands
Weill Medical College of Cornell University
University of California, Los Angeles

Completed

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Pleural Malignant Mesothelioma

United States
GemVax & Kael

Recruiting

GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy

Korea, Republic of
Genzyme, a Sanofi Company

Completed

Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States, Belgium
GemVax & Kael

Active, not recruiting

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

Mild to Moderate Alzheimer's Disease

Spain, United States, Netherlands, Poland
Genzyme, a Sanofi Company

Completed

Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS

Focal Segmental Glomerulosclerosis

United States, Germany, United Kingdom, Italy
TC Biopharm

Withdrawn

A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19

COVID - 19

United Kingdom
Green Cross Corporation

Unknown

A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

Hepatitis B

Korea, Republic of
GemVax & Kael

Recruiting

Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

Progressive Supranuclear Palsy

Korea, Republic of
Pharmexa A/S

Completed

A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.

Carcinoma, Hepatocellular

France, Germany, Spain
Green Cross Corporation

Completed

A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients

Hepatitis B Infection

Korea, Republic of
Green Cross Corporation
Korean Center for Disease Control and Prevention

Completed

A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 (GC1109)

Anthrax

Korea, Republic of
Green Cross Corporation

Unknown

HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102

Hepatitis B Infection

Korea, Republic of
RemeGen Co., Ltd.

Recruiting

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Solid Tumor

China
John Mascarenhas

Terminated

Anti-TGF-beta Therapy in Patients With Myelofibrosis

Primary Myelofibrosis | Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-essential Thrombocythemia Related Myelofibrosis

United States
GeneCradle Inc

Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

SMA II

China
GeneCradle Inc

Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Spinal Muscular Atrophy Type 3

China
Seoul National University Hospital
Green Cross Corporation; LSK Global Pharma Services Co. Ltd.

Completed

Efficacy and Safety of Anthrax Vaccine, GC1109

Anthrax

Korea, Republic of
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

HER2 Expressing or Mutated Advanced Malignant Solid Tumors

China
Green Cross Corporation

Unknown

Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

Neoplasm Metastasis | Gastric Cancer | Colorectal Cancer

Korea, Republic of
Green Cross Corporation

Completed

A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

Chronic Hepatitis B

Korea, Republic of
Ore Pharmaceuticals, Inc.

Unknown

Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Mild to Moderate Ulcerative Colitis

Canada, India
GemVax & Kael

Withdrawn

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

Moderate Alzheimer's Disease
GeneCradle Inc

Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Spinal Muscular Atrophy

China
GemVax & Kael

Completed

Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients

Alzheimer Disease

Korea, Republic of
Genzyme, a Sanofi Company

Completed

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Melanoma | Carcinoma, Renal Cell

United States
GemVax & Kael

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Samsung Pharmaceutical Co., Ltd.

Not yet recruiting

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

Moderate to Severe Alzheimer's Disease
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

HER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid Tumor

China, Australia, United States
Samsung Medical Center

Completed

GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

Glioblastoma, Adult | EGFR Amplification

Korea, Republic of
CellMed AG, a subsidiary of BTG plc.

Completed

Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Healthy

Germany
Oslo University Hospital

Completed

Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

Malignant Melanoma

Norway
Kael-GemVax Co., Ltd.
Quintiles, Inc.

Unknown

Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)

Inoperable Stage III Non-small Cell Lung Cancer
National Cancer Institute (NCI)

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Melanoma | Neoplasm Metastasis

United States
Centagen, Inc.

Completed

Effects of a 10 Component Dietary Supplement on Health and the Quality of Life

Quality of Life | Stress | Blood Pressure | Joint Instability | Immune Deficiency | Lung Function Decreased | HDL Low | Energy Supply; Deficiency | Concentration Ability Impaired

United States
TC Biopharm

Recruiting

ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB-008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML) (ACHIEVE)

Acute Myeloid Leukemia

United Kingdom
Forest Laboratories

Completed

Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Green Cross Corporation

Completed

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

Bacterial Infections

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Melanoma

United States
Forest Laboratories

Completed

A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)

Chronic Pancreatitis | Exocrine Pancreatic Insufficiency

United States, Italy, Ukraine
Green Cross Corporation

Completed

To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults

Bacterial Infections

Korea, Republic of
Daiichi Sankyo, Inc.

Completed

Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Shanghai Juncell Therapeutics

Recruiting

A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002) (MIZAR-002)

Melanoma | Efficacy | Adverse Drug Event | Safety | Tumor Infiltrating Lymphocytes

China
RemeGen Co., Ltd.

Recruiting

A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

Digestive Cancer

China
Coherent Biopharma (Suzhou) Co., Ltd.

Recruiting

A Study of CBP-1008 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Green Cross Corporation

Completed

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

Hepatitis B

Korea, Republic of
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Melanoma (Skin)

United States

Search clinical trials for: GC1008

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations